Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Allison B. Goldfine, MD
Joslin Diabetes Center
Study Director - Kathleen Jablonski, PhD
George Washington University
Study Director - Myrlene Staten, MD
National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
Study Director - Steven E. Shoelson, MD, PhD
Joslin Diabetes Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- University of California, San Diego
San Diego, California, United States
- Chapel Medical Group
New Haven, Connecticut, United States
- Emory University School of Medicine
Atlanta, Georgia, United States
- Kaiser Permanente
Tucker, Georgia, United States
- Indiana University
Indianapolis, Indiana, United States
- Tulane University Health Sciences Center
New Orleans, Louisiana, United States
- Medstar Research Institute
Hyattsville, Maryland, United States
- Dr. Rudo, Westminster, Md
Westminster, Maryland, United States
- Joslin Diabetes Center
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- North Shore Diabetes and Endocrine Associates
New Hyde Park, New York, United States
- Columbia University
New York, New York, United States
- Lang Medical Center
Queens, New York, United States
- Albert Einstein College of Medicine
The Bronx, New York, United States
- Carolina'S Health Care
Charlotte, North Carolina, United States
- University of North Carolina
Durham, North Carolina, United States
- University of Texas Southwestern
Dallas, Texas, United States
- Scott and White
Temple, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2008
- Primary completion
- 30 Sept 2012
- Completion
- —
- Last update posted
- 11 Dec 2017
- Registered enrollment
- 638
- Registry id
- NCT00799643
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.